To evaluate HIF-1α- and PGC-1α-significance as clinical prognostic factors in breast cancer patients, we followed up all patients' groups and correlated their overall and disease free survival with HIF-1α/ PGC-1α levels. This evidence concerns the gene PPARGC1A and breast carcinoma.